← Eichor
Condition: Immune Checkpoint Blockade Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immune Checkpoint Blockade

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (
EARLY_Phase 1 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT05141474Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients
Phase 1 · 1 location(s) · University of Florida · NCT06514898Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tu
Phase 2 · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT06630611Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases
Phase 1 · 1 location(s) · Nicholas Gulati · NCT05481658Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Phase 2 · 2 location(s) · British Columbia Cancer Agency · NCT04273061A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Phase 1 · 9 location(s) · Normunity AccelCo, Inc. · NCT07182149Neo-adjuvant Immunotherapy in Patients With Localized Melanoma
Phase 2 · 6 location(s) · UNICANCER · NCT07230613FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
Phase 1 · 1 location(s) · University Hospital Tuebingen · NCT05937295Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) a
Phase 1/Phase 2 · 43 location(s) · National Cancer Institute (NCI) · NCT06287775Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Phase N/A · 1 location(s) · John Kirkwood · NCT06599619A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1/Phase 2 · 8 location(s) · Memorial Sloan Kettering Cancer Center · NCT06835972Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Phase 2 · 6 location(s) · The Netherlands Cancer Institute · NCT03026140Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Pat
Phase 2 · 1 location(s) · EuroCityClinic LLC · NCT07130032Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Phase 2 · 1 location(s) · Chuangzhen Chen · NCT07071103Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids
Phase N/A · 2 location(s) · University Hospital, Basel, Switzerland · NCT07167251Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
Phase 2 · 1 location(s) · Hunan Province Tumor Hospital · NCT05284539Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Phase 2 · 5 location(s) · Gulam Manji · NCT06048484Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
EARLY_Phase 1 · 1 location(s) · Oslo University Hospital · NCT07341360Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · 39 location(s) · ModernaTX, Inc. · NCT05533697The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
Phase 2 · 1 location(s) · Benjamin Spieler · NCT06843551Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Phase N/A · 1 location(s) · Institut Claudius Regaud · NCT05867004Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Pa
Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT04159818Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in M
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06548789Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy
Phase 1 · 1 location(s) · UMC Utrecht · NCT06524570Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
Phase 2 · 1 location(s) · Catherine Spina · NCT05915442Autoimmunity After Checkpoint Blockade
Phase N/A · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT04119713A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07103395Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a B
Phase N/A · 1 location(s) · University Hospital, Brest · NCT05973344Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition Af
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT03942328
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.